Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

The Comparison of First-Line Dasatinib Therapy 70 mg/day Versus 100 mg/day in Newly Diagnosed Patients with Chronic Myeloid Leukemia in the Chronic Phase: a Prospective, Randomized, Multicenter 1-year Clinical Study

Title:	The Comparison of First-Line Dasatinib Therapy 70 mg/day Versus 100 mg/day in Newly Diagnosed Patients with Chronic Myeloid Leukemia in the Chronic Phase: a Prospective, Randomized, Multicenter 1-year Clinical Study
Authors:	Yu, Dan^Aff1; Yang, Zhuangzhi^Aff2; Han, Danlei^Aff3; Wu, Zhiwei^Aff4; Zhang, Lulu^Aff5; Qin, Jun^Aff6; Yuan, Guolin^Aff7; Zhang, Yicheng^Aff8; Zhang, Youshan^Aff9; Jiang, Daozi^Aff10; Chen, Shiming^Aff11; Huang, Xin^Aff12; Wang, Hongxiang^Aff13; Zou, Jing^Aff14; Zou, Xiuping^Aff2; Guo, Jingming^Aff3; Chen, Xu^Aff5; Wang, Li^Aff6; Lu, Tingting^Aff7; Liang, Caixia^Aff9; Yan, Li^Aff10; An, Hongyu^Aff11; Cheng, Hui^Aff1; Jiang, Rui^Aff4; Li, Weiming^{Aff14, Aff15, IDs1228802602320y_cor1}
Source:	Indian Journal of Hematology and Blood Transfusion. :1-7
Database:	Springer Nature Journals